Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Rabinowitz

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 29, 2024
Risk for hypertension and heart failure linked to high normal serum sodium and tonicity in electronic medical recordsJonathan Rabinowitz, Mahmoud Darawshi, Nuriel Burak, et al.
International Psychogeriatrics|August 2, 2006
Treating behavioral and psychological symptoms in patients with psychosis of Alzheimer's disease using risperidoneJonathan Rabinowitz, Ira Katz, Peter Paul De Deyn, et al.
Clinical Schizophrenia & Related Psychoses|October 1, 2010
Insight: demographic differences and associations with one-year outcome in schizophrenia and schizoaffective disorderBenjamin D R Wiffen, Jonathan Rabinowitz, W Wolfgang Fleischhacker, et al.
Suicide & Life-Threatening Behavior|February 11, 2012
Hopelessness as a predictor of attempted suicide among first admission patients with psychosis: a 10-year cohort studyE David Klonsky, Roman Kotov, Shelly Bakst, et al.
Schizophrenia Research|August 27, 2004
Correlates of insight in first episode psychosisMatcheri S Keshavan, Jonathan Rabinowitz, Goedele DeSmedt, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 21, 2016
Initial depression severity and response to antidepressants v. placebo: patient-level data analysis from 34 randomised controlled trialsJonathan Rabinowitz, Nomi Werbeloff, Francine S Mandel, et al.
Clinical Pharmacology and Therapeutics|August 10, 2019
Model-Informed Approach to Assess the Treatment Effect Conditional to the Level of Placebo ResponseRoberto Gomeni, Jonathan Rabinowitz, Navin Goyal, et al.
Journal of Affective Disorders|July 11, 2018
Determinants of antidepressant response: Implications for practice and future clinical trialsJonathan Rabinowitz, Nomi Werbeloff, Francine S Mandel, et al.
Schizophrenia Research|February 10, 2012
Treatment response trajectories and antipsychotic medications: examination of up to 18 months of treatment in the CATIE chronic schizophrenia trialStephen Z Levine, Jonathan Rabinowitz, Douglas Faries, et al.
Schizophrenia Research|October 18, 2011
Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE studyStephen Z Levine, Jonathan Rabinowitz, Haya Ascher-Svanum, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Medrxiv : the Preprint Server for Health Sciences|July 29, 2024
Risk for hypertension and heart failure linked to high normal serum sodium and tonicity in electronic medical recordsJonathan Rabinowitz, Mahmoud Darawshi, Nuriel Burak, et al.
International Psychogeriatrics|August 2, 2006
Treating behavioral and psychological symptoms in patients with psychosis of Alzheimer's disease using risperidoneJonathan Rabinowitz, Ira Katz, Peter Paul De Deyn, et al.
Clinical Schizophrenia & Related Psychoses|October 1, 2010
Insight: demographic differences and associations with one-year outcome in schizophrenia and schizoaffective disorderBenjamin D R Wiffen, Jonathan Rabinowitz, W Wolfgang Fleischhacker, et al.
Suicide & Life-Threatening Behavior|February 11, 2012
Hopelessness as a predictor of attempted suicide among first admission patients with psychosis: a 10-year cohort studyE David Klonsky, Roman Kotov, Shelly Bakst, et al.
Schizophrenia Research|August 27, 2004
Correlates of insight in first episode psychosisMatcheri S Keshavan, Jonathan Rabinowitz, Goedele DeSmedt, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 21, 2016
Initial depression severity and response to antidepressants v. placebo: patient-level data analysis from 34 randomised controlled trialsJonathan Rabinowitz, Nomi Werbeloff, Francine S Mandel, et al.
Clinical Pharmacology and Therapeutics|August 10, 2019
Model-Informed Approach to Assess the Treatment Effect Conditional to the Level of Placebo ResponseRoberto Gomeni, Jonathan Rabinowitz, Navin Goyal, et al.
Journal of Affective Disorders|July 11, 2018
Determinants of antidepressant response: Implications for practice and future clinical trialsJonathan Rabinowitz, Nomi Werbeloff, Francine S Mandel, et al.
Schizophrenia Research|February 10, 2012
Treatment response trajectories and antipsychotic medications: examination of up to 18 months of treatment in the CATIE chronic schizophrenia trialStephen Z Levine, Jonathan Rabinowitz, Douglas Faries, et al.
Schizophrenia Research|October 18, 2011
Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE studyStephen Z Levine, Jonathan Rabinowitz, Haya Ascher-Svanum, et al.
Pageof 11